369 related articles for article (PubMed ID: 15347586)
21. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
22. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
23. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
24. Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor.
Avila G; O'Brien JJ; Dirksen RT
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4215-20. PubMed ID: 11274444
[TBL] [Abstract][Full Text] [Related]
25. Mutations in RYR1 in malignant hyperthermia and central core disease.
Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
[TBL] [Abstract][Full Text] [Related]
26. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.
Weiss RG; O'Connell KM; Flucher BE; Allen PD; Grabner M; Dirksen RT
Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1094-102. PubMed ID: 15201141
[TBL] [Abstract][Full Text] [Related]
27. Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release.
Du GG; Khanna VK; Guo X; MacLennan DH
Biochem J; 2004 Sep; 382(Pt 2):557-64. PubMed ID: 15175001
[TBL] [Abstract][Full Text] [Related]
28. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
[TBL] [Abstract][Full Text] [Related]
29. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
30. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
[TBL] [Abstract][Full Text] [Related]
31. Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?
Dirksen RT; Avila G
Trends Cardiovasc Med; 2002 Jul; 12(5):189-97. PubMed ID: 12161072
[TBL] [Abstract][Full Text] [Related]
32. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes.
Sheridan DC; Carbonneau L; Ahern CA; Nataraj P; Coronado R
Biophys J; 2003 Dec; 85(6):3739-57. PubMed ID: 14645065
[TBL] [Abstract][Full Text] [Related]
33. A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR.
Estève E; Eltit JM; Bannister RA; Liu K; Pessah IN; Beam KG; Allen PD; López JR
J Gen Physiol; 2010 Jun; 135(6):619-28. PubMed ID: 20479110
[TBL] [Abstract][Full Text] [Related]
34. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect Of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors.
Censier K; Urwyler A; Zorzato F; Treves S
J Clin Invest; 1998 Mar; 101(6):1233-42. PubMed ID: 9502764
[TBL] [Abstract][Full Text] [Related]
35. RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes.
Eltit JM; Yang T; Li H; Molinski TF; Pessah IN; Allen PD; Lopez JR
J Biol Chem; 2010 Apr; 285(18):13781-7. PubMed ID: 20207743
[TBL] [Abstract][Full Text] [Related]
36. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
[TBL] [Abstract][Full Text] [Related]
37. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
Treves S; Jungbluth H; Muntoni F; Zorzato F
Curr Opin Pharmacol; 2008 Jun; 8(3):319-26. PubMed ID: 18313359
[TBL] [Abstract][Full Text] [Related]
38. Malignant hyperthermia and excitation-contraction coupling.
Melzer W; Dietze B
Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
[TBL] [Abstract][Full Text] [Related]
39. [Molecular pathology of malignant hyperthermia and central core disease].
Takagi A
Nihon Rinsho; 1997 Dec; 55(12):3307-14. PubMed ID: 9436456
[TBL] [Abstract][Full Text] [Related]
40. Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling.
Cheng W; Altafaj X; Ronjat M; Coronado R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19225-30. PubMed ID: 16357209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
